Results for tag: tyrosine kinase inhibitor Total Items Found: 11

Suresh Ramalingam on the FLAURA Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
egfr tki
EGFR mutation
esmo
lung cancer
nsclc
flaura trial
non-small cell lung cancer
osimertinib
tki
tyrosine kinase inhibitor

Created: 9/30/2019 2:08:20 PM

Bernardo Goulart on High Drug Costs in Stage IV NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
lung cancer
nsclc
quality care
out-of-pocket costs
survival rates
tkis
tyrosine kinase inhibitor

Created: 9/11/2019 5:29:14 PM

Neil Shah on CML NCCN Guidelines Updates

Type of Page:TapVideo
Edit This Item
Tags for this item:
cml
nccn
tki
NCCN guidelines
tyrosine kinase inhibitor
chronic myeloid leukemia

Created: 3/22/2019 3:22:39 PM

Heather Wakelee on EGFR and ALK Positive Advanced NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
alk
egfr
nsclc
tki
advanced nsclc
Thoracic Cancers Symposium
tyrosine kinase inhibitor

Created: 3/19/2019 7:27:17 PM

Johan Vansteenkiste on Immunotherapy and Targeted Treatments in NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2018
lung cancer
NSCLC
immunotherapy
targeted treatments
stage IV disease
tyrosine kinase inhibitor

Created: 10/20/2018 12:27:30 PM

Jerald Radich on Chronic-Phase CML Optimizing TKI

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
NCCN Hematologic Malignancies
CML
leukemia
chronic-phase CML
TKI
tyrosine kinase inhibitor
sequencing therapy
treatment-free remission

Created: 9/26/2018 4:08:58 PM

Ellin Berman, MD, on CML: Disease Management During Pregnancy

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
CML
chronic myeloid leukemia
pregnancy
disease management
TKI
tyrosine kinase inhibitor
fetal development
treatment plan

Created: 3/22/2018 6:09:07 PM

Eileen M. O’Reilly, MD, on Pancreatic and Hepatobiliary Cancers: Selecting High-Impact Targets

Type of Page:TapVideo
Edit This Item
Tags for this item:
GI Cancers Symposium 2017
Eileen M. O'Reilly
pancreatic cancer
hepatobiliary cancer
tyrosine kinase inhibitor
immunotherapy
DNA damage

Created: 1/23/2017 1:58:48 PM

Julie Vose, MD, MBA, and Mhairi Copland, MB, ChB, PhD, on CML: Data From the British DESTINY Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Julie Vose
Mhairi Copland
CML
chronic myeloid leukemia
DESTINY study
University of Nebraska Medical
Paul O'Gorman Leukaemia Research
tyrosine kinase inhibitor
dose decrease

Created: 12/5/2016 2:57:45 PM

Jean-Yves Douillard, MD, PhD, on New Perspectives in Small Cell Lung Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Jean-Yves Douillard
Centre R Gauducheau
SCLC
tyrosine kinase inhibitor
FGFR
IGFR
drug conjugates
Rova-T
DLL-3
immunotherapy
ipilumumab
nivolumab
pembrolizumab

Created: 1/31/2016 12:42:13 AM

Rolf A. Stahel, MD, on Results From the BELIEF Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ECC 2015
Rolf Stahel
University Hospital Zurich
BELIEF trial
EFGR mutation
tyrosine kinase inhibitor
erlotinib
T790M mutation
antiangiogenic agent
NSCLC
bevacizumab

Created: 1/31/2016 12:32:59 AM
Order By Item Count
Order Alphabetically